Benjamin Burgess, Mctm, Lssmbb
About Benjamin Burgess, Mctm, Lssmbb
Benjamin Burgess is an Operational Excellence Project Manager with extensive experience in the pharmaceutical industry. He currently leads initiatives at QuVa Pharma, Inc. and has founded 3rd Coast OpEx, a consulting service focused on lean six sigma methodologies.
Current Role at QuVa Pharma
Benjamin Burgess serves as the Operational Excellence Project Manager at QuVa Pharma, Inc. since 2021. His role is based in Sugar Land, Texas, and operates in a hybrid work environment. In this position, he focuses on implementing operational excellence initiatives to improve processes and enhance overall efficiency within the organization.
Previous Experience at Lonza
Prior to his current role, Benjamin worked at Lonza from 2019 to 2021 as part of the Operational Excellence team. His tenure lasted two years in Houston, Texas, where he contributed to various projects aimed at improving operational performance and efficiency within the company.
Founding 3rd Coast OpEx
In 2024, Benjamin founded 3rd Coast OpEx, a consulting service specializing in lean six sigma methodologies. As President, he leads the organization in providing operational excellence solutions to clients in Texas and surrounding areas. The firm focuses on enhancing operational efficiency and quality through proven methodologies.
Educational Background
Benjamin holds a Master's degree in Clinical Translation Management from the University of St. Thomas, which he completed in 2018. He also earned a Bachelor's of Science in Chemistry from The University of Texas at Austin, where he studied from 2010 to 2014. His educational background supports his expertise in operational excellence and quality management.
Achievements in Operational Excellence
Throughout his career, Benjamin has identified over $20 million in yearly savings and throughput increases through root cause analysis and continuous improvement initiatives. His work emphasizes the application of lean six sigma methodologies to enhance drug quality and safety, contributing to the development of safer and more cost-effective medicines.